Current and future commitment to hematology research.
This article provides an overview of the National Heart Lung and Blood Institute's (NHLBI) current and future commitment to hematology research. The paper comprises nine sections: (1) a brief history of how NHLBI incorporated blood research in its mission; (2) a summary of the traditional areas of research interest for blood diseases and resources; (3) a description of how NHLBI has assured and continues to assure a safe blood supply; (4) the current and future plans for transfusion medicine and cellular therapy research; (5) research support for hemoglobinopathies and red cell disorders; (6) research support for thrombosis and hemostatic disorders; (7) current and future research of hematopoietic stem cell biology, and aplastic and preneoplastic conditions; (8) future training for hematologists, and (9) a concluding summary.
Peterson
Charles M
CM
Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Rockledge II, Room 10158, Bethesda, MD 20892, USA. petersoc@nhlbi.nih.gov
Harvath
Liana
L
D006405:Hematology / Q000379:methods* / Q000639:trends*; D006801:Humans; D009316:National Institutes of Health (U.S.); D012106:Research / Q000639:trends; D012107:Research Design; D012109:Research Support as Topic; D014481:United States